These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 10492594

  • 1. Ciprofloxacin-resistant Salmonella typhi.
    Baliga S, Shenoy S, Vidyalaxmi, Pereira P.
    Natl Med J India; 1999; 12(3):138. PubMed ID: 10492594
    [No Abstract] [Full Text] [Related]

  • 2. Ciprofloxacin-resistant Salmonella typhi.
    Bhat KG, Suresh K.
    Natl Med J India; 1999; 12(2):88. PubMed ID: 10416331
    [No Abstract] [Full Text] [Related]

  • 3. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.
    Threlfall EJ, Ward LR.
    Emerg Infect Dis; 2001; 7(3):448-50. PubMed ID: 11384525
    [Abstract] [Full Text] [Related]

  • 4. Nalidixic acid screening test for the detection of decreased susceptibility to ciprofloxacin in Salmonella typhi.
    Ciraj AM, Seema DS, Bhat GK, Shivananda PG.
    Indian J Pathol Microbiol; 2001 Oct; 44(4):407-8. PubMed ID: 12035350
    [No Abstract] [Full Text] [Related]

  • 5. Clinical resistance to ciprofloxacin in Salmonella typhi.
    Rodrigues C, Mehta A, Andrews R, Joshi VR.
    J Assoc Physicians India; 1998 Mar; 46(3):323-4. PubMed ID: 11273362
    [No Abstract] [Full Text] [Related]

  • 6. Synergism of ciprofloxacin and trimethoprim against Salmonella enterica serovar typhi isolates showing reduced susceptibility to ciprofloxacin.
    Mandal S, Mandal MD, Pal NK.
    Chemotherapy; 2004 Jun; 50(3):152-4. PubMed ID: 15272228
    [Abstract] [Full Text] [Related]

  • 7. Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India.
    Gupta V, Kaur J, Kaistha N.
    Trop Doct; 2009 Jan; 39(1):28-30. PubMed ID: 19211419
    [Abstract] [Full Text] [Related]

  • 8. Multidrug-resistant Salmonella enterica serovar typhi isolates with high-level resistance to ciprofloxacin in Dhaka, Bangladesh.
    Ahmed D, D'Costa LT, Alam K, Nair GB, Hossain MA.
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3516-7. PubMed ID: 17005846
    [No Abstract] [Full Text] [Related]

  • 9. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R, Desjardins M, McCarthy AE, Ramotar K, Jessamine P, Guibord C, Toye B.
    BMC Infect Dis; 2004 Sep 20; 4():36. PubMed ID: 15380025
    [Abstract] [Full Text] [Related]

  • 10. Drug resistance in Salmonella typhi in north India with special reference to ciprofloxacin.
    Nath G, Tikoo A, Manocha H, Tripathi AK, Gulati AK.
    J Antimicrob Chemother; 2000 Jul 20; 46(1):149-50. PubMed ID: 10882709
    [No Abstract] [Full Text] [Related]

  • 11. Low-level quinolone-resistance in multi-drug resistant typhoid.
    Mirza SH, Khan MA.
    J Coll Physicians Surg Pak; 2008 Jan 20; 18(1):13-6. PubMed ID: 18452661
    [Abstract] [Full Text] [Related]

  • 12. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R, Paglietti B, Murgia M, Dawar R, Uzzau S, Cappuccinelli P, Deb M, Aggarwal P, Rubino S.
    J Antimicrob Chemother; 2006 Dec 20; 58(6):1139-44. PubMed ID: 17071955
    [Abstract] [Full Text] [Related]

  • 13. In vitro effects of ampicillin, ciprofloxacin and ofloxacin on Salmonella typhi within human monocyte-derived macrophages.
    Ekinci B, Coban AY, Durupinar B.
    J Chemother; 2001 Dec 20; 13(6):661-3. PubMed ID: 11806630
    [No Abstract] [Full Text] [Related]

  • 14. Ciprofloxacin-resistant typhoid with incomplete response to cefotaxime.
    Prabha Adhikari MR, Baliga S.
    J Assoc Physicians India; 2002 Mar 20; 50():428-9. PubMed ID: 11924574
    [No Abstract] [Full Text] [Related]

  • 15. Etiological agents of bacteraemia and antibiotic susceptibility pattern in Kathmandu Model Hospital.
    Amatya NM, Shrestha B, Lekhak B.
    JNMA J Nepal Med Assoc; 2007 Mar 20; 46(167):112-8. PubMed ID: 18274566
    [Abstract] [Full Text] [Related]

  • 16. Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin--an emerging problem in Bangladesh.
    Rahman MM, Haq JA, Morshed MA, Rahman MA.
    Int J Antimicrob Agents; 2005 Apr 20; 25(4):345-6. PubMed ID: 15784317
    [No Abstract] [Full Text] [Related]

  • 17. A need to revise ciprofloxacin breakpoints for Salmonella in human beings.
    Gupta V, Kaur J.
    Int J Infect Dis; 2008 Nov 20; 12(6):e143-4. PubMed ID: 18514007
    [No Abstract] [Full Text] [Related]

  • 18. Nalidixic acid-resistant Salmonella typhi in Mumbai.
    Rodrigues C, Mehta A, Joshi VR.
    Natl Med J India; 1999 Nov 20; 12(2):88. PubMed ID: 10416332
    [No Abstract] [Full Text] [Related]

  • 19. Scattergram analysis to explore the emerging problem related to in vitro susceptibility test for Salmonella enterica serovar Typhi to ciprofloxacin.
    Pal NK, Mandal S, Mandal MD.
    Int J Antimicrob Agents; 2004 Sep 20; 24(3):297-9. PubMed ID: 15325437
    [Abstract] [Full Text] [Related]

  • 20. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
    Butt T, Khan MY, Ahmad RN, Salman M, Afzal RK.
    J Coll Physicians Surg Pak; 2006 Jan 20; 16(1):31-4. PubMed ID: 16441985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.